This inventor holds 6 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignees: Ube Industries, Inc., Daiichi Sankyo Company, Limited. Active years: 1999-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Ube, JP (1999 - 2003)
- Yamaguchi, JP (2012)
Company Filing History:


Years Active: 1999-2012
Title: Naoyuki Yokota: Innovator in Pharmaceutical Processes
Introduction
Naoyuki Yokota is a prominent inventor based in Ube, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the production of high-purity compounds. With a total of 6 patents to his name, Yokota's work has had a notable impact on the industry.
Latest Patents
One of his latest patents is titled "Process for producing high-purity prasugrel and acid addition salt thereof." This invention focuses on providing prasugrel hydrochloride with a reduced content of OXTP. The method involves dissolving free prasugrel containing OXTP in an inert solvent and adding hydrochloric acid dropwise to the solution for reaction. Another significant patent is for "4-fluoro-3-oxocarboxylic esters and process for producing the same," which further showcases his innovative approach to chemical processes.
Career Highlights
Throughout his career, Naoyuki Yokota has worked with notable companies such as Ube Industries, Inc. and Daiichi Sankyo Company, Limited. His experience in these organizations has allowed him to refine his skills and contribute to various advancements in pharmaceutical technology.
Collaborations
Yokota has collaborated with esteemed colleagues, including Kikuo Ataka and Yasuhito Yamamoto. These partnerships have fostered a creative environment that has led to the development of groundbreaking inventions.
Conclusion
Naoyuki Yokota's contributions to the pharmaceutical industry through his innovative patents and collaborations highlight his role as a key inventor in the field. His work continues to influence the production of high-purity compounds, showcasing the importance of innovation in pharmaceuticals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile